LGG-15. Late mortality and morbidity of adult survivors of childhood glioma treated across three decades: a report from the Childhood Cancer Survivor Study

PURPOSE: Pediatric low-grade glioma therapy has evolved to delay or eliminate radiation. The impact of therapy changes on long-term outcomes remains unknown. METHODS: Cumulative incidence of late mortality (death >5 years from diagnosis), subsequent neoplasms (SNs), and chronic health conditions...

Descripción completa

Detalles Bibliográficos
Autores principales: de Blank, Peter M K, Lange, Katharine R, Xing, Mengqi, Salehabadi, Sedigheh Mirzaei, Srivatava, Deokumar, Brinkman, Tara M, Ness, Kirsten K, Oeffinger, Kevin C, Neglia, Joseph, Krull, Kevin R, Yasui, Yutaka, Nathan, Paul, Howell, Rebecca, Turcotte, Lucie, Leisenring, Wendy, Armstrong, Gregory T, Bowers, Daniel C, Okcu, M Fatih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Low Grade Glioma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164667/
http://dx.doi.org/10.1093/neuonc/noac079.330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164667/
http://dx.doi.org/10.1093/neuonc/noac079.330

Ejemplares similares